Results - Announcements
Epigral Ltd share price rallied 8.81% to Rs 951.2 after the company's net profit tumbled by 34.75% to Rs 65.08 crore, while revenue from operations slightly gained 5.76% to Rs 745.99 crore in Q3FY26 over Q2FY26.
The market capitalization of Specialty Chemicals industry group stocks on BSE stood at Rs 5.64 lakh crore, climbing 13.76%. It has marginally improved by 0.04% over last one week and eased lower by 7.04% in last one month while the market capitalization of Epigral Ltd has improved by 5.88% and 14.87% in the same period respectively.
Profit before tax (PBT) of Epigral Ltd stood at Rs 87.58 crore in Q3 FY26, jumping 25.74% year-on-year, and tanking 34.51% quarter-on-quarter. EBITDA came in at Rs 130 crore, declining 0.25% YoY and plunging by 25.59% sequentially.
Total expenses rose by 14.95% to Rs 654.11 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 469.4 crore, inching up 9.12% YoY, while employee benefits expense was at Rs 33.7 crore, dropping 8.17% YoY.
For the TTM ended FY26, revenue from operations surged 32.19% to Rs 2550.13 crore, while net profit soared by 82.62% to Rs 357.69 crore, compared to previous TTM. EBITDA jumped by 48263% to Rs 695.51 crore, and PBT witnessed a strong rise of 86.10% to Rs 541.09 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 440.56 crore in FY26, as against Rs 397.64 crore in FY25.
Epigral Ltd plunged by 43.98% in last one year, underperforming the benchmark BSE Sensex which has slipped by 9.87% during the same period.